Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Non-Current Assets (2016 - 2025)

Fresenius Medical Care AG (FMS) has 14 years of Non-Current Assets data on record, last reported at $27.1 billion in Q4 2022.

  • For Q4 2022, Non-Current Assets fell 6.4% year-over-year to $27.1 billion; the TTM value through Dec 2022 reached $27.1 billion, down 6.4%, while the annual FY2022 figure was $28.0 billion, 3.31% down from the prior year.
  • Non-Current Assets reached $27.1 billion in Q4 2022 per FMS's latest filing, down from $28.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $28.9 billion in Q4 2021 and bottomed at $20.0 billion in Q4 2018.
  • Average Non-Current Assets over 5 years is $26.3 billion, with a median of $27.4 billion recorded in 2019.
  • Peak YoY movement for Non-Current Assets: surged 37.21% in 2019, then dropped 6.4% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $20.0 billion in 2018, then soared by 37.21% to $27.4 billion in 2019, then grew by 1.83% to $27.9 billion in 2020, then increased by 3.66% to $28.9 billion in 2021, then decreased by 6.4% to $27.1 billion in 2022.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $27.1 billion in Q4 2022, $28.9 billion in Q4 2021, and $27.9 billion in Q4 2020.